Diabetes care

publication venue for

Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40. 2023
Addendum. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S41-S48. 2023
Addendum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S49-S67. 2023
Erratum. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S49-S67. 2023
Erratum. 2. Classification and diagnosis of diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40. 2023
Erratum. 10. Cardiovascular disease and risk management: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S158-S190. 2023
Ambient Heat and Risk of Serious Hypoglycemia in Older Adults With Diabetes Using Insulin in the U.S. and Taiwan: A Cross-National Case-Crossover Study. 2023
Associations Between Postdischarge Care and Cognitive Impairment-Related Hospital Readmissions for Ketoacidosis and Severe Hypoglycemia in Adults With Diabetes. 2023
Diabetes Risk Factors and Bone Microarchitecture as Assessed by High-Resolution Peripheral Quantitative Computed Tomography in Adults With Long-Standing Type 1 Diabetes. 2023
Prediction of Cardiometabolic Health Through Changes in Plasma Proteins With Intentional Weight Loss in the DiRECT and DIADEM-I Randomized Clinical Trials of Type 2 Diabetes Remission. 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE Trial. 2023
Introduction and Methodology: Standards of Care in Diabetes-2023.. 46. 2023
Summary of Revisions: Standards of Care in Diabetes-2023.. 46. 2023
To Correct or Not to Correct: Lost in Inpatient Translation.. 45. 2022
Prescription Patterns of Cardiovascular- and Kidney-Protective Therapies Among Patients With Type 2 Diabetes and Chronic Kidney Disease. 2022
Projected Impact of the Medicare Part D Senior Savings Model on Diabetes-Related Health and Economic Outcomes Among Insulin Users Covered by Medicare.. 45. 2022
Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D).. 45. 2022
Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis.. 45. 2022
Association Between Change in Accelerometer-Measured and Self-Reported Physical Activity and Cardiovascular Disease in the Look AHEAD Trial. 2022
Role of the Gut in the Temporal Changes of β-Cell Function After Gastric Bypass in Individuals With and Without Diabetes Remission. 2021
Preintervention Clinical Determinants and Measured β-Cell Function As Predictors of Type 2 Diabetes Remission After Roux-en-Y Gastric Bypass Surgery. 2021
Corneal Confocal Microscopy Predicts the Development of Diabetic Neuropathy: A Longitudinal Diagnostic Multinational Consortium Study.. 44. 2021
Spinal Inhibitory Dysfunction in Patients With Painful or Painless Diabetic Neuropathy.. 44. 2021
Does the Association Between Hemoglobin A_1c and Risk of Cardiovascular Events Vary by Residential Segregation? The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.. 44. 2021
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.. 44. 2021
Presence of Liver Steatosis Is Associated With Greater Diabetes Remission After Gastric Bypass Surgery.. 44. 2020
Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study.. 44. 2020
Diagnosis of Neuropathy and Risk Factors for Corneal Nerve Loss in Type 1 and Type 2 Diabetes: A Corneal Confocal Microscopy Study.. 44. 2020
Rapid Corneal Nerve Fiber Loss: A Marker of Diabetic Neuropathy Onset and Progression.. 43. 2020
Genetic Discrimination Between LADA and Childhood-Onset Type 1 Diabetes Within the MHC.. 43. 2019
Reports of Lactic Acidosis Attributed to Metformin, 2015-2018.. 43. 2019
Long-term Effects of Disasters on Seniors With Diabetes: Evidence From Hurricanes Katrina and Rita.. 42. 2019
Does the Association of Diabetes With Stroke Risk Differ by Age, Race, and Sex? Results From the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.. 42. 2019
Type 1 Diabetes Risk in African-Ancestry Participants and Utility of an Ancestry-Specific Genetic Risk Score.. 42. 2019
Impact of Peer Support on Acute Care Visits and Hospitalizations for Individuals With Diabetes and Depressive Symptoms: A Cluster-Randomized Controlled Trial.. 41. 2018
First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes.. 41. 2018
Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts.. 41. 2018
Association of Hemoglobin A_1c and Wound Healing in Diabetic Foot Ulcers.. 41. 2018
Comparative Safety of Sulfonylureas and the Risk of Sudden Cardiac Arrest and Ventricular Arrhythmia.. 41. 2018
Mortality in Type 1 Diabetes in the DCCT/EDIC Versus the General Population.. 39. 2016
Association of Weight Loss Maintenance and Weight Regain on 4-Year Changes in CVD Risk Factors: the Action for Health in Diabetes (Look AHEAD) Clinical Trial.. 39. 2016
Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up.. 39. 2016
Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels.. 39. 2016
Consequences of Comorbidity of Elevated Stress and/or Depressive Symptoms and Incident Cardiovascular Outcomes in Diabetes: Results From the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study.. 39. 2015
Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes.. 38. 2015
Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes.. 38. 2015
Small nerve fiber quantification in the diagnosis of diabetic sensorimotor polyneuropathy: comparing corneal confocal microscopy with intraepidermal nerve fiber density.. 38. 2015
Normative values for corneal nerve morphology assessed using corneal confocal microscopy: a multinational normative data set.. 38. 2015
Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes.. 38. 2015
Effect of hypoglycemia on brain structure in people with type 2 diabetes: epidemiological analysis of the ACCORD-MIND MRI trial.. 37. 2014
Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes.. 37. 2014
Adjusting glucose-stimulated insulin secretion for adipose insulin resistance: an index of β-cell function in obese adults.. 37. 2014
Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance.. 37. 2014
Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial.. 37. 2014
Metabolic syndrome, C-reactive protein, and mortality in U.S. Blacks and Whites: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.. 37. 2014
Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K.. 37. 2014
Diabetic retinopathy and other ocular findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.. 37. 2014
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.. 37. 2014
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study: 30th anniversary presentations.. 37. 2014
Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.. 37. 2014
Cardiometabolic risk is associated with atherosclerotic burden and prognosis: results from the partners coronary computed tomography angiography registry.. 37. 2013
Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy.. 36. 2013
The long-term effects of type 1 diabetes treatment and complications on health-related quality of life: a 23-year follow-up of the Diabetes Control and Complications/Epidemiology of Diabetes Interventions and Complications cohort.. 36. 2013
Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action.. 36. 2013
The association of skin intrinsic fluorescence with type 1 diabetes complications in the DCCT/EDIC study.. 36. 2013
Inflammation and cognitive dysfunction in type 2 diabetic carotid endarterectomy patients.. 36. 2013
Insulin resistance, incident cardiovascular diseases, and decreased kidney function among nondiabetic American Indians: the Strong Heart Study.. 36. 2013
Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes.. 36. 2013
Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment.. 36. 2013
Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.. 36. 2013
Cardiovascular characteristics in subjects with increasing levels of abnormal glucose regulation: the Strong Heart Study.. 36. 2012
Generic medications and blood pressure control in diabetic hypertensive subjects: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.. 36. 2012
Heterogeneity in phenotype of usher-congenital hyperinsulinism syndrome: hearing loss, retinitis pigmentosa, and hyperinsulinemic hypoglycemia ranging from severe to mild with conversion to diabetes.. 36. 2012
Improvement in outcomes of clinical islet transplantation: 1999-2010.. 35. 2012
Association of prediabetes and diabetes with stroke symptoms: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.. 35. 2012
Does diabetes care differ by type of chronic comorbidity?: An evaluation of the Piette and Kerr framework.. 35. 2012
Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action.. 35. 2012
Lipoprotein-associated phospholipase A(2) mass and activity and risk of cardiovascular disease in a population with high prevalences of obesity and diabetes: the Strong Heart Study.. 35. 2012
Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women.. 34. 2011
Cardiac geometry and function in diabetic or prediabetic adolescents and young adults: the Strong Heart Study.. 34. 2011
Self-reported long total sleep duration is associated with metabolic syndrome: the Guangzhou Biobank Cohort Study.. 34. 2011
Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.. 34. 2011
Hemoglobin A1c, fasting glucose, and cardiovascular risk in a population with high prevalence of diabetes: the strong heart study.. 34. 2011
Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1.. 34. 2011
Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes.. 34. 2011
Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a french prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR).. 34. 2011
Trends in initial lower extremity amputation rates among Veterans Health Administration health care System users from 2000 to 2004.. 34. 2011
Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study.. 34. 2011
Hidden complexities in assessment of glycemic outcomes: are quality rankings aligned with treatment?. 33. 2010
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.. 33. 2010
Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy.. 33. 2010
Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.. 33. 2010
The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery.. 33. 2010
Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans.. 33. 2010
Improved pancreatic beta-cell function in type 2 diabetic patients after lifestyle-induced weight loss is related to glucose-dependent insulinotropic polypeptide.. 33. 2010
Blood pressure control in diabetes: temporal progress yet persistent racial disparities: national results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.. 33. 2010
Costs and consequences associated with newer medications for glycemic control in type 2 diabetes.. 33. 2010
Insufficient control of blood pressure and incident diabetes.. 32. 2009
Antidiabetic action of bezafibrate in a large observational database.. 32. 2009
Abnormal LDIflare but normal quantitative sensory testing and dermal nerve fiber density in patients with painful diabetic neuropathy.. 32. 2008
Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity.. 31. 2008
Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.. 31. 2008
Economic benefits of intensive insulin therapy in critically Ill patients: the targeted insulin therapy to improve hospital outcomes (TRIUMPH) project.. 31. 2008
Individualized, non-age-based glycemic control in elderly veterans with diabetes.. 31. 2008
Perception of neighborhood problems, health behaviors, and diabetes outcomes among adults with diabetes in managed care: the Translating Research Into Action for Diabetes (TRIAD) study.. 31. 2007
Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy.. 31. 2007
Insulin reduces plasma arginase activity in type 2 diabetic patients.. 31. 2007
Neurovascular factors in wound healing in the foot skin of type 2 diabetic subjects.. 30. 2007
Burden of comorbid medical conditions and quality of diabetes care.. 30. 2007
Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT).. 30. 2007
Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes.. 30. 2007
Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration.. 30. 2007
Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.. 30. 2007
Corneal sensitivity is reduced and relates to the severity of neuropathy in patients with diabetes.. 30. 2007
Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial.. 30. 2007
Impaired skin microvascular reactivity in painful diabetic neuropathy.. 30. 2007
Impact of self-reported patient characteristics upon assessment of glycemic control in the Veterans Health Administration.. 30. 2007
Does patient behavior or access factors have the largest influence on screening in type 1 diabetes?. 30. 2007
Is the number of documented diabetes process-of-care indicators associated with cardiometabolic risk factor levels, patient satisfaction, or self-rated quality of diabetes care? The Translating Research into Action for Diabetes (TRIAD) study.. 29. 2006
Who is tested for diabetic kidney disease and who initiates treatment? The Translating Research Into Action For Diabetes (TRIAD) Study.. 29. 2006
Comparison of weighted performance measurement and dichotomous thresholds for glycemic control in the Veterans Health Administration.. 29. 2006
Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors.. 29. 2006
Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study.. 29. 2006
Race, ethnicity, socioeconomic position, and quality of care for adults with diabetes enrolled in managed care: the Translating Research Into Action for Diabetes (TRIAD) study.. 28. 2005
Organizational factors affecting the adoption of diabetes care management processes in physician organizations.. 27. 2004
Managed care organization and the quality of diabetes care: the Translating Research Into Action for Diabetes (TRIAD) study.. 27. 2004
Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data.. 27 Suppl 2. 2004
Applying diabetes-related Prevention Quality Indicators to a national cohort of veterans with diabetes.. 26. 2003
Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study.. 26. 2003
Out-of-pocket costs and diabetes preventive services: the Translating Research Into Action for Diabetes (TRIAD) study.. 26. 2003
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin.. 25. 2002
Incidence of diabetes in American Indians of three geographic areas: the Strong Heart Study.. 25. 2002
Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers.. 24. 2001
Performance status of health care facilities changes with risk adjustment of HbA1c.. 23. 2000
Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes.. 22. 1999
Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis.. 21. 1998
Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM.. 20. 1997
Low risk of post-cesarean section infection in insulin-requiring diabetic women.. 19. 1996
Reliability and validity of cardiovascular and vasomotor autonomic function tests.. 17. 1994
Leukocyte scanning with 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers.. 15. 1992
Role of diabetologist in evaluating diabetic retinopathy.. 14. 1991
Artificial Intelligence-Based Classification of Diabetic Peripheral Neuropathy From Corneal Confocal Microscopy Images. 2021
Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246.. 43. 2020
Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes.. 43. 2020
Response to Comment on Almurdhi et al. Reduced Lower-Limb Muscle Strength and Volume in Patients With Type 2 Diabetes in Relation to Neuropathy, Intramuscular Fat, and Vitamin D Levels. Diabetes Care 2016;39:441-447.. 39. 2016
Subjects With Extreme-Duration Type 1 Diabetes Exhibit No Structural or Functional Abnormality on Cardiac MRI.. 39. 2016
Small Fiber Neuropathy in Patients With Latent Autoimmune Diabetes in Adults.. 38. 2015
Corneal confocal microscopy shows an improvement in small-fiber neuropathy in subjects with type 1 diabetes on continuous subcutaneous insulin infusion compared with multiple daily injection.. 38. 2015
Medalists with extreme duration of type 1 diabetes exhibit only mild diastolic dysfunction and myocardial fibrosis.. 38. 2015
Response to comment on Guest et al. Clinical outcomes and cost-effectiveness of continuous positive airway pressure to manage obstructive sleep apnea in patients with type 2 diabetes in the U.K. Diabetes Care 2014;37:1263-1271.. 37. 2014
Liver transplantation: a potential cure for hepatogenous diabetes?. 36. 2013
Effects of proximal gut bypass on glucose tolerance and insulin sensitivity in humans.. 36. 2013
Characteristics and outcomes of subjects with diabetic foot ulceration.. 35. 2012
An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin: response to Barnett et al.. 30. 2007
Malignant melanoma misdiagnosed as a diabetic foot ulcer.. 30. 2007
The Biogun: a novel way of eradicating methicillin-resistant Staphylococcus aureus colonization in diabetic foot ulcers. Response to Dang et al.. 29. 2006
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: Response to Bowker et Al.. 29. 2006
Eliminating inpatient sliding-scale insulin: a reeducation project with medical house staff: response to Baldwin et al.. 28. 2005
Climate Change and Ambient Temperature Extremes: Association With Serious Hypoglycemia, Diabetic Ketoacidosis, and Sudden Cardiac Arrest/Ventricular Arrhythmia in People With Type 2 Diabetes. 2022
Bariatric Surgery in Patients With Obesity and Latent Autoimmune Diabetes in Adults (LADA). 2020
Effect of Food Order on Ghrelin Suppression. 2018
Incidence and Clinical Features of Diabetic Ketoacidosis After Bariatric and Metabolic Surgery. 2016
Food Order Has a Significant Impact on Postprandial Glucose and Insulin Levels. 2015
Effect of bariatric surgery versus intensive medical management on diabetic ophthalmic outcomes. 2015
Response to comments on Brethauer et al. Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes care 2014;37:e51-e52. 2014
Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. 2014
The Biogun: A novel way of eradicating methicillin-resistant Staphylococcus aureus colonization in diabetic foot ulcers. 2006
Type 2 Diabetes Remission: A New Mission in Diabetes Care.. 47. 2024
Neuropathy of impaired glucose tolerance and its measurement.. 33. 2010
Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. 2011
Diabetes surgery: a new approach to an old disease. 2009
Diabetic neuropathies: a statement by the American Diabetes Association. 2005
Diabetic somatic neuropathies. 2004
1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2023. 2023
10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2023. 2023
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes-2023. 2023
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2023. 2023
14. Children and Adolescents: Standards of Care in Diabetes-2023. 2023
16. Diabetes Care in the Hospital: Standards of Care in Diabetes-2023. 2023
17. Diabetes Advocacy: Standards of Care in Diabetes-2023. 2023
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. 2023
3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Care in Diabetes-2023. 2023
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023. 2023
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2023. 2023
6. Glycemic Targets: Standards of Care in Diabetes-2023. 2023
7. Diabetes Technology: Standards of Care in Diabetes-2023. 2023
8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2023. 2023
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023. 2023
Bariatric Surgery in Obese Patients With Type 1 Diabetes. 2016

VIVO Weill Cornell Medical College

Diabetes care Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)